The study was published January 30 in the International Journal of Cardiology and shows that Elucid's AI software can quantify vessel structure and plaque composition using data from a routine CT angiography (CTA), according to the firm.

A team led by Dr. Akos Varga-Szemes and Dr. Joseph Schoepf of the Medical University of South Carolina conducted the research.